United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66993-100_265f6517-11c1-4af8-9871-ef7fdde464e6
- Product NDC
- 66993-100
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- levetiracetam
- Labeler
- Prasco Laboratories
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20250120
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVETIRACETAM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (66993-100-06) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51) · 66993-100-06
- 60 BLISTER PACK in 1 CARTON (66993-100-60) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-100-51) · 66993-100-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →